West Pharmaceutical Services, Inc. (WST)
02:29 pm EDT; Powered by IEX
Buy analyst rating
Average analyst stock price above current stock price
Revenue growth lower than the industry and sector averages
Company’s profitability is declining
Forward P/E ratio high relative to industry peers
Forward PEG ratio high relative to industry peers
- WST quarterly revenue growth was 7.40%, lower than the industry and sector average revenue growth (10.76% and 7.51%, respectively). See WST revenue growth chart.
- WST profitability is declining. The YoY profit margin change was -0.09 percentage points. See WST profitability chart.
- WST forward P/E ratio is 37.96, which is high compared to its industry peers’ P/E ratios. See WST forward P/E ratio chart.
- WST PEG ratio (P/E adjusted for growth) is 3.06, which is high compared to its industry peers’ PEG ratios. See WST PEG chart.